Europe Neuroblastoma Market and Competitive Landscape 2012-2017 & Forecasts to 2021 & 2025

DUBLIN, Dec. 18, 2017 /PRNewswire/ --

The "Europe Neuroblastoma Market and Competitive Landscape - 2017" report has been added to Research and Markets' offering.

Europe Neuroblastoma Market and Competitive Landscape - 2017, provides comprehensive insights into Neuroblastoma pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Neuroblastoma market size and drug sales. This research also provides insights into Neuroblastoma epidemiology and late stage pipeline.

The report is classified into nine sections - Neuroblastoma overview with definitions, symptoms, etiology, diagnosis, treatment options; Neuroblastoma pipeline insights covering late stage clinical trials pipeline; Neuroblastoma prevalence trends by countries; Neuroblastoma market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries - Germany, France, Italy, Spain, UK, Europe.

Research Scope:

• Neuroblastoma pipeline: Find out the drugs in clinical trials for Neuroblastoma by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
• Neuroblastoma epidemiology: Find out the prevalence of Neuroblastoma by countries - Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
• Neuroblastoma products: Identify key products marketed and prescribed for Neuroblastoma by brand name, by molecule, by company, by branded / generic, by countries - Europe, Germany, France, Italy, Spain, UK, Japan
• Neuroblastoma market size: Find out the market size for Neuroblastoma drugs by countries - Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
• Neuroblastoma drug sales: Find out the sales of Neuroblastoma drugs by countries - Europe, Germany, France, Italy, Spain, UK
• Neuroblastoma drugs sales forecast: Sales forecast for Neuroblastoma drugs to 2021 by countries - Europe, Germany, France, Italy, Spain, UK, Japan
• Neuroblastoma market share analysis: Find out the market shares of Neuroblastoma drugs and outlook by countries - Europe, Germany, France, Italy, Spain, UK, Japan

Benefits of this Research:

• Evaluate commercial market opportunities for Neuroblastoma drugs
• Synthesize insights for business development & licensing
• Track market size, competitor drug sales, market shares in Neuroblastoma market
• Develop in-depth knowledge of competition and markets
• Analyze sales data to update your brand planning trackers
• Develop tactics and strategies to take advantage of opportunities in the market
• Track market trends and analyze key events in Neuroblastoma market
• Develop forecast models, healthcare frameworks, or economic models
• Answer key business questions; supports decision making in R&D to long term marketing strategies

Key Topics Covered:

1. Neuroblastoma: Disease Overview

2. Neuroblastoma Pipeline Insights

3. Neuroblastoma Epidemiology Analysis

4. Germany Neuroblastoma Market Insights

5. France Neuroblastoma Market Insights

6. Italy Neuroblastoma Market Insights

7. Spain Neuroblastoma Market Insights

8. UK Neuroblastoma Market Insights

9. Europe Neuroblastoma Market Insights

For more information about this report visit https://www.researchandmarkets.com/research/fpf53z/europe?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets